Infectious disease diagnostics
8 European H2020 organizations list this as part of their work — 4 as their primary capability.
Most active in this area
- THE UNIVERSITY OF STIRLING
Scottish university strong in aquaculture science, water quality monitoring, and food-biodiversity trade-offs, with growing environmental observation capabilities.
“EbolaMoDRAD and VHFMoDRAD focus on rapid bedside diagnostics for viral haemorrhagic fevers, including Ebola.”
UK38 projects - BIOMERIEUX SA
Global in-vitro diagnostics company contributing infectious disease detection, AMR testing, and precision molecular diagnostics to European health research consortia.
“Central theme across PERFORM, ND4ID, DIAMONDS, VALUE-Dx, COMBACTE-CDI, ImmunoSep, and VITAL — all focused on diagnosing or managing infectious diseases.”
PrimaryFR11 projects - TATAA BIOCENTER AB
Swedish SME specializing in PCR-based molecular diagnostics, multi-omics biomarker validation, and point-of-care test development for health research consortia.
“TB diagnostics (PITBUL), sepsis diagnosis (SMARTDIAGNOS), and COVID-19 rapid testing (CORONADX) cover bacterial, systemic, and viral infections respectively.”
SMESE7 projects - FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS
Global non-profit accelerating infectious disease diagnostics — from clinical validation and AI-driven trials to wearable detection technology.
“Core thread across Mofina (filovirus testing), VALUE-Dx (antimicrobial resistance diagnostics), UNITE4TB (tuberculosis treatment), and EUROLEISH-NET (leishmaniasis).”
PrimaryCH5 projects - BIOVENDOR - LABORATORNI MEDICINA AS
Czech diagnostics SME developing biomarker assays, point-of-care devices, and reagent kits for infection, cancer, and neurodegeneration research.
“DIAGORAS addressed oral and respiratory tract infections with antibiotic resistance identification from saliva samples.”
PrimarySMECZ3 projects - ACOBIOM
French biotech SME specializing in biomarker discovery and in vitro diagnostic development for cancer, psychiatric, and infectious diseases.
“LeiSHield-MATI involved prognostic and diagnostic tools for leishmaniasis, including immune response profiling.”
SMEFR3 projects - BIOCARTIS NV
Belgian diagnostics SME specialising in lab-on-a-chip technology, microfluidic MEMS, and molecular diagnostics for infectious disease.
“ND4ID (2016–2020) was an MSCA training network explicitly focused on developing new diagnostics for infectious diseases, where Biocartis served as an industry participant.”
PrimarySMEBE2 projects - GALAPAGOS
Belgian biotech specialising in cystic fibrosis drug development and personalised medicine for rare CFTR mutations.
“Participated as a third party in ND4ID (2016–2020), an MSCA Innovative Training Network on new diagnostics for infectious diseases.”
BE2 projects